Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Guojiang Wei

机构:Renji Hospital · ORCID:0009-0003-8766-0174

发表论文 6 篇 · 总被引 101 次 · h-index 5

代表论文

  • Drug‐Loaded Bacillus Calmette–Guérin Bacteria for Immuno‐Chemo Combo Therapy in Bladder Cancer (2024 · Advanced Materials · 被引 39)
  • SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance (2025 · Cell Death Discovery · 被引 28)
  • Effect of renal sympathetic denervation on ventricular and neural remodeling (2018 · Herz · 被引 17)
  • Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer (2024 · Translational Oncology · 被引 12)
  • Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization (2024 · Frontiers in Genetics · 被引 5)
  • Rapid establishment of KRAS-driven bladder cancer initiation and immune escape models using genetically engineered mice and organoid approaches (2026 · Frontiers in Immunology)